Skip to content

Clinical trials

Phase 1/2 trials in Belarus

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Belarus Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20141
20152
20161
20173
20184
20191
20204
20212
20226
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting7
Unknown status5
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus17
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology2
Biocad2
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology2
The Republican Research and Practical Center for Epidemiology and Microbiology2
AO GENERIUM1
Janssen Research & Development, LLC1
Molecular Templates, Inc.1
Teva Branded Pharmaceutical Products R&D, Inc.1
Viatris Innovation GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2
Lupus Erythematosus, Systemic2
Lymphoma, B-Cell2
Breast Neoplasms1
Burns1
COVID-191
Carcinoma, Transitional Cell1
Chronic Periodontitis1

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.